Apellis Pharmaceuticals, Inc. (APLS)

USD 34.02

(-1.48%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 788.73 Million 760.21 Million 881.76 Million 960.56 Million 389.24 Million 203.53 Million
Total Current Assets 766.33 Million 719.52 Million 824.04 Million 917.19 Million 373.09 Million 202.43 Million
Cash And Short Term Investments 352.29 Million 551.8 Million 700.55 Million 877.64 Million 351.98 Million 176.26 Million
Cash and Cash Equivalents 352.29 Million 551.8 Million 640.19 Million 565.77 Million 351.98 Million 176.26 Million
Short Term Investments 4.35 Million 6.5 Million 60.35 Million 311.86 Million - -
Net Receivables 206.44 Million 7.72 Million 10.1 Million 25 Million - -
Inventory 146.36 Million 85.71 Million 16.28 Million 1.00 - -
Other Current Assets 61.22 Million 36.65 Million 70.67 Million 26.87 Million 1.3 Million 1.83 Million
Total Non-Current Assets 22.39 Million 40.69 Million 57.71 Million 43.37 Million 16.15 Million 1.09 Million
Net PPE 21.09 Million 24.89 Million 26.07 Million 24.52 Million 15.76 Million 977.91 Thousand
Good Will And Intangible Assets - - - - - -
Good Will - - - - - -
Intangible Assets - - - - - -
Long-Term Investments - - - - - -
Tax Assets - - - - - -
Other Non Current Assets 1.3 Million 15.79 Million 31.64 Million 18.85 Million 385.08 Thousand 116.42 Thousand
Other Assets - - - - - -
Total Liabilities 594.2 Million 590.34 Million 683.1 Million 756.01 Million 355.01 Million 42.56 Million
Total Current Liabilities 247.59 Million 167.61 Million 131.84 Million 128.32 Million 65.75 Million 17.02 Million
Account Payables 37.51 Million 37.34 Million 16.9 Million 8.47 Million 8.36 Million 10.25 Million
Tax Payables - - - - - -
Short Term Debt 6.44 Million 5.62 Million 4.11 Million 3.68 Million 2.6 Million 1.66 Million
Deferred Revenue - - 103.23 Million 111.93 Million - -
Other Current Liabilities 203.63 Million 124.64 Million 7.58 Million 4.23 Million 54.78 Million 5.1 Million
Total Non Current Liabilities 346.61 Million 422.73 Million 551.25 Million 627.68 Million 289.26 Million 25.53 Million
Long-Term Debt 93.03 Million 107.08 Million 206.1 Million 374.04 Million 154.42 Million 25.37 Million
Deferred Revenue Non Current - - - - - -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 253.58 Million 315.64 Million 345.15 Million 253.63 Million 134.83 Million 158.78 Thousand
Other Liabilities - - - - - -
Total Equity 194.52 Million 169.87 Million 198.66 Million 204.55 Million 34.22 Million 160.97 Million
Stock Holders Equity 194.52 Million 169.87 Million 198.66 Million 204.55 Million 34.22 Million 160.97 Million
Common Stock 12 Thousand 11 Thousand 10 Thousand 8000.00 6393.00 5628.00
Retained Earnings -2.83 Billion -2.3 Billion -1.65 Billion -926.34 Million -581.47 Million -276.76 Million
Accumulated other comprehensive income -3.54 Million -875 Thousand -2.09 Million -117 Thousand -153.77 Thousand -122.8 Thousand
Common Stock Equity 194.52 Million 169.87 Million 198.66 Million 204.55 Million 34.22 Million 160.97 Million
Capital Lease Obligation 11.45 Million 19.97 Million 21.19 Million 18.9 Million 14.46 Million -
Total Investments 4.35 Million 6.5 Million 60.35 Million 311.86 Million - -
Total Debt 110.92 Million 112.71 Million 210.22 Million 377.73 Million 157.03 Million 27.04 Million
Net Debt -241.37 Million -439.08 Million -429.97 Million -188.04 Million -194.95 Million -149.22 Million

Balance Sheet Charts